CULP, INC. FINANCIAL INFORMATION RELEASE |
CONSOLIDATED STATEMENTS OF CASH FLOWS |
FOR THE TWELVE MONTHS ENDED MAY 3, 2009 AND APRIL 27, 2008 |
Unaudited |
(Amounts in Thousands) |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | TWELVE MONTHS ENDED |
| | | | | | | | | | | |
| | | | | | | | Amounts |
| | | | | | | | May 3, | | | * April 27, |
| | | | | | | | 2009 | | | 2008 |
| | | | | | | | | | | |
Cash flows from operating activities: | | | | | | |
| Net (loss) income | | $ | (38,842 | ) | | $ | 5,385 | |
| Adjustments to reconcile net (loss) income to net cash | | | | | | |
| | provided by operating activities: | | | | | | |
| | | Depreciation | | | 6,712 | | | | 5,548 | |
| | | Amortization of other assets | | | 488 | | | | 373 | |
| | | Stock-based compensation | | | 425 | | | | 618 | |
| | | Excess tax benefit related to stock options exercised | | | - | | | | (17 | ) |
| | | Deferred income taxes | | | 33,231 | | | | (919 | ) |
| | | (Gain) loss on impairment of equipment | | | (32 | ) | | | 289 | |
| | | Restructuring expenses, net of gain on sale of related assets | | | 7,960 | | | | 140 | |
| | | Changes in assets and liabilities, net of effects of acquisition of assets: | | | | | |
| | | | Accounts receivable | | | 8,957 | | | | 2,242 | |
| | | | Inventories | | | 12,855 | | | | 5,236 | |
| | | | Other current assets | | | 46 | | | | 496 | |
| | | | Other assets | | | 10 | | | | (188 | ) |
| | | | Accounts payable-trade | | | (5,365 | ) | | | (924 | ) |
| | | | Accrued expenses | | | (1,721 | ) | | | (445 | ) |
| | | | Accrued restructuring | | | (579 | ) | | | (1,926 | ) |
| | | | Income taxes | | | (1,377 | ) | | | 456 | |
| | | | | Net cash provided by operating activities | | 22,768 | | | | 16,364 | |
| | | | | | | | | | | |
Cash flows from investing activities: | | | | | | |
| Capital expenditures | | | (1,970 | ) | | | (4,846 | ) |
| Net cash paid for acquisition of assets | | (11,365 | ) | | | - | |
| Proceeds from the sale of buildings and equipment | | 4,607 | | | | 2,723 | |
| | | | | Net cash used in investing activities | | (8,728 | ) | | | (2,123 | ) |
| | | | | | | | | | | |
Cash flows from financing activities: | | | | | | |
| Proceeds from lines of credit | | | - | | | | 1,339 | |
| Payments on lines of credit | | | - | | | | (3,932 | ) |
| Proceeds from the issuance of long-term debt | | 11,000 | | | | - | |
| Payments on vendor-financed capital expenditures | | (1,236 | ) | | | (642 | ) |
| Payments on capital lease obligation | | | (754 | ) | | | - | |
| Payments on long-term debt | | | (16,055 | ) | | | (16,737 | ) |
| Debt issuance costs | | | (133 | ) | | | - | |
| Proceeds from common stock issued | | | 21 | | | | 459 | |
| Excess tax benefit related to stock options exercised | | - | | | | 17 | |
| | | | | Net cash used in financing activities | | (7,157 | ) | | | (19,496 | ) |
| | | | | | | | | | | |
Increase (decrease) in cash and cash equivalents | | | 6,883 | | | | (5,255 | ) |
| | | | | | | | | | | |
Cash and cash equivalents at beginning of year | | | 4,914 | | | | 10,169 | |
| | | | | | | | | | | |
Cash and cash equivalents at end of year | | $ | 11,797 | | | $ | 4,914 | |
| | | | | | | | | | | |
| | | | | | | | | | | |
Free Cash Flow (1) | | $ | 23,415 | | | $ | 13,616 | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
(1) Free Cash Flow reconciliation is as follows: | | | | | |
| | | | | | | | FY 2009 | | | FY 2008 |
A) | Net cash provided by operating activities | | $ | 22,768 | | | $ | 16,364 | |
B) | Minus: Capital Expenditures | | | (1,970 | ) | | | (4,846 | ) |
C) | Add: Proceeds from the sale of buildings and equipment | | | 4,607 | | | | 2,723 | |
D) | Minus: Payments on vendor-financed capital expenditures | | | (1,236 | ) | | | (642 | ) |
E) | Minus: Payments on capital lease obligation | | | (754 | ) | | | - | |
F) | Add: Excess tax benefit related to stock options exercised | | | - | | | | 17 | |
| | | | | | | $ | 23,415 | | | $ | 13,616 | |
| | | | | | | | | | | |
| | | | | | | | | | | |
* Derived from audited financial statements. | | | | | | |